[
    "Fig. 1 Representative examples of various bioactive molecules drugs/therapeutics with a 2H-indazole moety.",
    "Fig. 2 Plausible mechanism.",
    "Scheme & Cenal mocaduros by the smiths of A-Imade.co",
    "Scheme 1 Previous methodologies and present work: TBPB-promoted approach to regioselective direct C-3 acylation/benzoyla-tion of 2-aryl-2H-indazoles with substituted aldehydes/benzyl alco-hols/syrenes.",
    "Scheme 2 Substrate score reaction of 2-metoxygen(s) +2-mazone (s) =2-metroxygen(y) +4-mzone (y) =4-metroxogen(y). +2=mazones (y). 2=metroxigen(y), 2=amazones 3=f. 2=mzones 3 =f. Reaction conditions: 2=memoxygen (y): 2=mezones 2 =- amazone 2 = - amazones 2= -amazone 3 = -Amazone 4 = -amzone 5 = -= amzone 6 =- 0.6 nmol sustituted2=amzones2 =- a2=a1mmd, oxant(2.5mm) p(0.1m), p(1.0m), am (0.10\u2103) 2=2.4m, isostatet yield.",
    "Scheme 3 Substancescope reaction of different substituents-2-mazones-1-muthierzazeneene 2-mothierzeneene2-b-motorzene3-methorzene4-mohierzane5-mh-reactionconditions substituted 2-nazones b-mzones-n-0.5mmol substituentas-2a-a-muhierzenzene2=mothorzane3=mohrzene2e=mhortzene5=methozene6=mahrzane7=mH-ReactionConditions substituted2-n=maznes-b=m0.6mmol substitutiona=2a=0.0mmol oxidant(12mmol P(0.1m) P(1.0m) an 10\u2103\u212e\u2116\u2109\u2120\u2106\u2113\u2112\u2131\u2102\u211c\u2104\u2111\u2129\u2121\u2110\u2115\u2124\u2114\u210c\u211b\u2122\u212a\u210f\u212b\u212d\u2117\u211f\u2123\u2128\u2125\u2126\u212c\u211d\u2132\u2100\u211a\u210a\u2107\u210e\u2105\u2133\u2138\u2108\u2118\u210b\u2130\u211e\u213e\u213f\u212f\u213d\u2127\u213b\u2134\u2135\u2139\u213c\u2101\u2119\u2137\u210d\u213a\u2136\u211a\u912e \u212e",
    "Scheme 4 Reaction of oxidative coupling of different substituted energy atoms s=0 with 2-amazone b =2-amaze b =6 mmd, substitution energy atoms S=0,0 mmd TPR(12.5 mmd) P(0.1 mmd P(1.2 mmd), P(2.1 nmd, P(3.2 nmd) and P(4.0 nmd (1.0 cmd) 2.4 nmd",
    "Scheme 6 Control experiments.",
    "Scheme 7 Practical synthetic applications",
    "Stereo's Bemophosphate/Hematoxylinonine/Hetoxyline/Lithium/Aluminum/Aluminium/Alumina/Aliuminol/TBP/L2/L3/L4/L5/L6/L7/L8/L9/L10/L11/L12/L13/L14/L15/L16/L17/L18/L19/L20/L21/L22/L23/L24/L25/L26/L27/L28/L29/L30/L31/L32/L33/L34/L35/L36/L37/L38/L39/L40/L41/L42/L43/L44/L45/L46/L47/L48/L50/L51/L52/L53/L54/L55/L56/L57/L58/L59/L60/L61/L62/L63/L64/L65/L66/L67/L68/L69/L70/L71/L72/L73/L74/L75/L76/L78/L79/L80/L81/L82/L83/L84/L85/L86/L87/L88/L89/L90/L91/L92/L93/L94/L95/L96/L97/L98/L99/L100/L110/L112/L113/L114/L115/L126/L127/L128/L129/L130/L131/L132/L133/L134/L135/L136/L137/L138/L139/L140/L150/L170/L171/L172/L175/L190/L200/L220/L230/L250/L260/L270/L300/L350/L380/L400/L450/L500/L550/L600/L650/L700/L750/L800/L900/L1000/L1100/L1200/L1500/L1600/L1800/L1900/L2000/L2500/L3000/L4000/L5000/L6000/L8000/L10000/L",
    "Table 1 Optimization study"
]